A retrospective study involving multiple tumour types treated with axitinib, an oral VEGF inhibitor, has shown an association between diastolic blood pressure of ⩾90 mm Hg and survival (O. Rixe et al, 2008; Rini et al, 2008b). Here, VEGFA is linked to neoplasm.